Service de bactériologie, Institut des Agents Infectieux, Hospices Civils de Lyon, Lyon, France.
Team StaPath, CIRI-Centre International de Recherche en Infectiologie, Université de Lyon, Inserm, U1111, Université Claude Bernard Lyon 1, CNRS, UMR5308, ENS de Lyon, Lyon, France.
J Antimicrob Chemother. 2024 Nov 4;79(11):2742-2749. doi: 10.1093/jac/dkae325.
Phage therapy is a highly promising approach to address the challenge that is presented by the global burden of antimicrobial resistance. Given the natural specificity of phages, phage susceptibility testing (PST) is a prerequisite for successful personalized therapy, allowing the selection of active phages from large and diverse collections. However, the issue of an easy-to-use and standardized technique remains. In this review, we describe the principles, advantages and drawbacks of two routinely used PST techniques: plaque and growth kinetic assays. These are labour-intensive and time-consuming methods that require automation of one or more steps, including preparation of test panels, incubation, reading and analysis of results. In addition to automation, there is an urgent need to establish a reference method to enable efficient of PST techniques selection of therapeutic phages. We discuss knowledge gaps and parameters that need to be investigated to work towards this goal.
噬菌体疗法是应对全球抗菌药物耐药性挑战的极具前景的方法。鉴于噬菌体的天然特异性,噬菌体药敏试验(PST)是成功进行个体化治疗的前提,可以从大量不同的噬菌体库中选择有活性的噬菌体。然而,一种易于使用和标准化的技术仍然是一个问题。在这篇综述中,我们描述了两种常用 PST 技术——平板法和生长动力学检测法的原理、优点和缺点。这些方法劳动强度大,耗时耗力,需要对一个或多个步骤进行自动化,包括测试板的制备、孵育、读数和结果分析。除了自动化之外,还迫切需要建立一个参考方法,以实现 PST 技术治疗性噬菌体选择的高效化。我们讨论了实现这一目标所需研究的知识空白和参数。